دورية أكاديمية
أعرض في EDS

Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations.

التفاصيل البيبلوغرافية
العنوان: Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations.
المؤلفون: Deng K; Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA., Pan XF; Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA.; Section of Epidemiology and Population Health & Department of Gynecology and Obstetrics, Ministry of Education Key Laboratory of Birth Defects and Related Diseases of Women and Children & National Medical Products Administration Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, West China Second University Hospital Sichuan University Chengdu Sichuan China., Voehler MW; Department of Chemistry and Center for Structural Biology Vanderbilt University Nashville TN USA., Cai Q; Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA., Cai H; Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA., Shu XO; Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA., Gupta DK; Vanderbilt Translational and Clinical Cardiovascular Research Center and Division of Cardiovascular Medicine, Department of Medicine Vanderbilt University Medical Center Nashville TN USA., Lipworth L; Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA., Zheng W; Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA., Yu D; Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA.
المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2024 May 21; Vol. 13 (10), pp. e034364. Date of Electronic Publication: 2024 May 10.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Oxford : Wiley-Blackwell
مواضيع طبية MeSH: Coronary Disease*/blood , Coronary Disease*/epidemiology , Coronary Disease*/ethnology , Coronary Disease*/diagnosis , Lipoproteins*/blood , Black or African American* , White People* , Apolipoproteins*/blood , Biomarkers*/blood, Humans ; Male ; Female ; Middle Aged ; Prospective Studies ; Case-Control Studies ; Aged ; Lipids/blood ; Incidence ; Asian/statistics & numerical data ; Adult ; United States/epidemiology ; Risk Factors ; Risk Assessment ; Magnetic Resonance Spectroscopy ; Triglycerides/blood
مستخلص: Background: Comprehensive blood lipoprotein profiles and their association with incident coronary heart disease (CHD) among racially and geographically diverse populations remain understudied.
Methods and Results: We conducted nested case-control studies of CHD among 3438 individuals (1719 pairs), including 1084 White Americans (542 pairs), 1244 Black Americans (622 pairs), and 1110 Chinese adults (555 pairs). We examined 36 plasma lipids, lipoproteins, and apolipoproteins, measured by nuclear magnetic resonance spectroscopy, with incident CHD among all participants and subgroups by demographics, lifestyle, and metabolic health status using conditional or unconditional logistic regression adjusted for potential confounders. Conventionally measured blood lipids, that is, total cholesterol, triglycerides, low-density lipoprotein-cholesterol, and high-density lipoprotein-cholesterol, were each associated with incident CHD, with odds ratios (ORs) being 1.33, 1.32, 1.24, and 0.79 per 1-SD increase among all participants. Seventeen lipoprotein biomarkers showed numerically stronger associations than conventional lipids, with ORs per 1-SD among all participants ranging from 1.35 to 1.57 and a negative OR of 0.78 (all false discovery rate <0.05), including apolipoprotein B100 to apolipoprotein A1 ratio (OR, 1.57 [95% CI, 1.45-1.7]), low-density lipoprotein-triglycerides (OR, 1.55 [95% CI, 1.43-1.69]), and apolipoprotein B (OR, 1.49 [95% CI, 1.37-1.62]). All these associations were significant and consistent across racial groups and other subgroups defined by age, sex, smoking, obesity, and metabolic health status, including individuals with normal levels of conventionally measured lipids.
Conclusions: Our study highlighted several lipoprotein biomarkers, including apolipoprotein B/ apolipoprotein A1 ratio, apolipoprotein B, and low-density lipoprotein-triglycerides, strongly and consistently associated with incident CHD. Our results suggest that comprehensive lipoprotein measures may complement the standard lipid panel to inform CHD risk among diverse populations.
References: Nat Commun. 2023 Feb 3;14(1):604. (PMID: 36737450)
Anal Chem. 2014 Oct 7;86(19):9887-94. (PMID: 25180432)
Eur Heart J. 2021 Nov 7;42(42):4324-4332. (PMID: 34293083)
Front Cardiovasc Med. 2023 May 18;10:1105342. (PMID: 37273877)
BMJ Open Diabetes Res Care. 2016 Jul 20;4(1):e000246. (PMID: 27547417)
Anal Chem. 2017 Aug 1;89(15):8004-8012. (PMID: 28692288)
Lancet. 2001 Dec 15;358(9298):2026-33. (PMID: 11755609)
Int J Cancer. 2018 Mar 15;142(6):1209-1217. (PMID: 29119548)
Lancet Diabetes Endocrinol. 2021 Jun;9(6):373-392. (PMID: 34022156)
PLoS Med. 2015 May 26;12(5):e1001830; discussion e1001830. (PMID: 26011727)
Eur J Prev Cardiol. 2016 Jan;23(1):41-9. (PMID: 25062744)
Eur Heart J. 2021 Sep 7;42(34):3227-3337. (PMID: 34458905)
Nat Med. 2023 Apr;29(4):936-949. (PMID: 37076741)
Circulation. 2019 Jun 18;139(25):e1082-e1143. (PMID: 30586774)
Am J Epidemiol. 2005 Dec 1;162(11):1123-31. (PMID: 16236996)
J Am Coll Cardiol. 2007 Feb 6;49(5):547-53. (PMID: 17276177)
J Am Coll Cardiol. 2018 Jul 10;72(2):170-172. (PMID: 29976290)
Circ Heart Fail. 2017 Mar;10(3):. (PMID: 28255010)
Diagnostics (Basel). 2023 Feb 15;13(4):. (PMID: 36832218)
J Clin Med. 2023 Sep 03;12(17):. (PMID: 37685804)
Eur J Prev Cardiol. 2020 Oct;27(15):1617-1626. (PMID: 31996015)
J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):26-37. (PMID: 20173283)
BMC Health Serv Res. 2014 Apr 29;14:195. (PMID: 24779477)
Circulation. 2014 Feb 4;129(5):570-9. (PMID: 24192801)
Circulation. 2023 Feb 21;147(8):e93-e621. (PMID: 36695182)
Circulation. 2016 May 31;133(22):2141-8. (PMID: 27185168)
Anal Chem. 2018 Oct 16;90(20):11962-11971. (PMID: 30211542)
J Am Coll Cardiol. 2018 Feb 13;71(6):620-632. (PMID: 29420958)
JAMA Cardiol. 2022 Jul 1;7(7):672-680. (PMID: 35583863)
J Am Heart Assoc. 2023 Oct 17;12(20):e029552. (PMID: 37815053)
J Am Heart Assoc. 2021 Dec 7;10(23):e021995. (PMID: 34845932)
Lancet. 2019 Dec 14;394(10215):2173-2183. (PMID: 31810609)
J Am Heart Assoc. 2016 Apr 29;5(5):. (PMID: 27130348)
PLoS Med. 2020 Mar 23;17(3):e1003062. (PMID: 32203549)
Atherosclerosis. 2004 Oct;176(2):371-7. (PMID: 15380461)
Am J Clin Nutr. 2014 Aug;100(2):693-700. (PMID: 24944055)
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):465-474. (PMID: 33115266)
Circulation. 2011 May 24;123(20):2292-333. (PMID: 21502576)
J Am Coll Cardiol. 2020 Dec 8;76(23):2725-2735. (PMID: 33272366)
Int J Epidemiol. 2015 Jun;44(3):810-8. (PMID: 25733578)
Am J Epidemiol. 1998 Oct 15;148(8):750-60. (PMID: 9786230)
JAMA Cardiol. 2022 Mar 01;7(3):250-256. (PMID: 34773460)
Anal Chem. 1995 Mar 1;67(5):793-811. (PMID: 7762816)
Eur Heart J. 2019 Sep 7;40(34):2883-2896. (PMID: 31102408)
Eur J Prev Cardiol. 2015 Oct;22(10):1321-7. (PMID: 25633587)
Clin Chem. 2013 May;59(5):723-5. (PMID: 23487171)
Circulation. 2019 Sep 10;140(11):e596-e646. (PMID: 30879355)
J Am Coll Cardiol. 2023 Jan 17;81(2):136-152. (PMID: 36631208)
Anal Chem. 2017 Nov 7;89(21):11405-11412. (PMID: 28937204)
Eur J Prev Cardiol. 2022 Mar 11;29(2):e53-e64. (PMID: 33580780)
Eur Heart J. 2020 Jan 1;41(1):111-188. (PMID: 31504418)
Ann Intern Med. 2017 Dec 5;167(11):ITC81-ITC96. (PMID: 29204622)
Int J Epidemiol. 2022 Jun 13;51(3):996-1011. (PMID: 34405869)
Metabolites. 2020 Apr 23;10(4):. (PMID: 32340170)
Eur J Prev Cardiol. 2022 Feb 09;28(18):1991-2000. (PMID: 33624048)
Eur Heart J. 2009 Mar;30(6):710-7. (PMID: 18676970)
Int J Epidemiol. 2021 Jul 9;50(3):893-901. (PMID: 33130851)
Clin Chem. 2021 Jan 8;67(1):143-153. (PMID: 33257928)
Lancet. 2020 Oct 17;396(10258):1204-1222. (PMID: 33069326)
J Clin Lipidol. 2017 Sep - Oct;11(5):1223-1233. (PMID: 28754224)
JAMA. 2007 Aug 15;298(7):776-85. (PMID: 17699011)
J Am Coll Cardiol. 2018 Jul 10;72(2):156-169. (PMID: 29976289)
فهرسة مساهمة: Keywords: apolipoprotein; coronary heart disease; lipid; lipoprotein; nuclear magnetic resonance; racially diverse populations
تواريخ الأحداث: Date Created: 20240510 Date Completed: 20240521 Latest Revision: 20240618
رمز التحديث: 20240618
مُعرف محوري في PubMed: PMC11179824
DOI: 10.1161/JAHA.124.034364
PMID: 38726919
قاعدة البيانات: MEDLINE
الوصف
تدمد:2047-9980
DOI:10.1161/JAHA.124.034364